OBIO Orchestra BioMed Holdings, Inc.
Orchestra BioMed Holdings, Inc. (OBIO) Insider Activity
What the officers, directors and large holders did with their own shares. Only open-market purchases and sales count toward the totals — grants, option exercises and shares withheld for tax are compensation mechanics, not decisions, and they're listed separately below.
How much of that selling was preplanned? 100% planned / 0% discretionary
Largest single sale: $86.1K.
Where they traded
Last open-market purchase: November 9, 2026 .
Recent open-market activity
| Date | Insider | Role | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|---|
| Buy | 1,200,000 | $5.00 | $6.0M | 10,756,063 | |||
| Fain Eric S | Director | Buy | 20,000 | $5.00 | $100.0K | 119,630 | |
| Pacitti David | Director | Buy | 20,000 | $5.00 | $100.0K | 74,750 | |
| Hochman David P | See Remarks | Buy | 5,000 | $5.00 | $25.0K | 437,916 | |
| Taylor Andrew Lawrence | Chief Financial Officer | Buy | 1,000 | $5.00 | $5.0K | 590,989 | |
| Sherman Darren | See Remarks | Sell 10b5-1 | 15,000 | $5.74 | $86.1K | 1,104,402 −1.3% of holding | |
| Sherman Darren | See Remarks | Buy | 2,000 | $5.33 | $10.7K | 2,000 |
Form 4s are due within two business days of a transaction, so this is close to real time — unlike the quarterly 13F data on the Institutional tab. A single large sale often reflects a prearranged 10b5-1 plan rather than a fresh view, so read a pattern of sales rather than any one of them.